Document is current
Any future updates will be listed below
-
Authors
Raghunandan, Sharmila https://orcid.org/0000-0002-1149-8524
Qayed, Muna
Watkins, Ben K. https://orcid.org/0000-0002-6675-8071
Graiser, Michael
Gorfinkel, Lev
Westbrook, Adrianna
Gillespie, Scott
Bratrude, Brandi https://orcid.org/0000-0002-1498-1001
Petrovic, Aleksandra
Suessmuth, Yvonne
Horan, John
Kean, Leslie S.
Langston, Amelia A. https://orcid.org/0000-0003-0649-1915
- License Information
-
More Information
Article History
Received: 20 June 2023
Revised: 2 July 2023
Accepted: 11 July 2023
First Online: 14 August 2023
Competing interests
: There is a relevant conflict of interest, described below. MQ reports Honoraria at Vertex and Novartis. LK reports the following - Novartis: Research Funding; Bluebird Bio: Research Funding; Vertex: Consultancy; EMD-Serono: Research Funding; Bristol Myers Squibb: Patents & Royalties: clinical trial, Research Funding; Magenta: Research Funding; Mammoth Biosciences: Current equity holder in private company, Current holder of stock options in a privately-held company; HiFiBio: Consultancy. The remaining authors declare no competing financial interests.
